Anomali Premium Digital Risk Protection (PDRP)
If you are requesting the PDRP service for the first time, refer to Requesting the Anomali PDRP Service Trial Activation for details.
Anomali Premium Digital Risk Protection (PDRP), formerly known as Anomali Targeted Threat Monitoring (ATTM+), is a premium threat intelligence feed available to new Anomali customers. The PDRP service includes a dashboard and feed of observables and Threat Models focused on threats to your organization and assets, giving intelligence analysts the automated threat intelligence needed to respond to targeted domain attacks quickly and effectively. Identified domains and compromised credentials are imported into Anomali ThreatStream to provide visibility and enriched intelligence to fully protect assets and increased efficiencies by operationalizing this targeted intelligence within ThreatStream.
Key Benefits of PDRP:
-
Defend your brand against targeted attacks and brand abuse to maintain loyalty and trust with your customers
-
Continuously monitor domains for cybersquatters and domain hijacking to prevent phishing and malware attacks
-
Increase visibility into external threats to prevent sensitive data leaks and help mitigate risk before damage can occur
-
Receive clear and detailed alerts on suspected threats with recommendations on how to remediate the threat quickly and effectively
PDRP provides data tailored to your organization based on the following alerts:
-
Exposed subdomains
-
Leaked credentials
-
Similar domain registration
-
Domain expiration
-
Domain hijacking
-
Rogue apps
-
Fake Twitter accounts
-
Pastebin brand mentions
-
Leaked documents
-
Leaked code monitor
-
Trademark application filing
-
Email vulnerability
-
SSL certificate validity
-
Leaked employee emails
For more information, see Tagging Taxonomy and Information Provided by PDRP Alerts
Anomali offers PDRP on a free trial basis to allow you to gauge its impact on intelligence workflows before purchasing a subscription. For more information, see Requesting Anomali PDRP Trial.